For example, AZD9291 is a third‐generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR‐TKI) used for the prevention of recurrent metastasis of nonsmall cell lung cancer (NSCLC). This evidence concerns the gene EGFR and lung cancer.